Inebilizumab treatment in a patient with co-occurring AQP4-IgG positive neuromyelitis optica spectrum disorder and myasthenia gravis: a case report and literature review

Inebilizumab treatment in a patient with co-occurring AQP4-IgG positive neuromyelitis optica spectrum disorder and myasthenia gravis: a case report and literature review

ObjectiveThis study aims to delineate the clinical features underlying the concurrent disease of neuromyelitis optica spectrum disorder (NMOSD) and myasthenia gravis (MG), and to identify efficacious therapeutic strategies.BackgroundNMOSD and MG are uncommon autoimmune diseases that infrequently co-...

Full description

Saved in:

Bibliographic Details
Main Authors:	Xiaoqian Song, Jingjiao Chen, Chenyang Jin, Yilong Peng, Yuewen Sun, Xueping Zheng
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-01-01
Series:	Frontiers in Immunology
Subjects:	neuromyelitis optica spectrum disorder myasthenia gravis inebilizumab anti-AQP4 antibodies anti-acetylcholine receptors antibodies
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2024.1528989/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Exploring the clinical significance of anti-acetylcholine receptor antibody titers, changes, and change rates in Myasthenia Gravis
by: Lijun Luo, et al.
Published: (2025-01-01)

Neuromyelitis optica spectrum disorder: epidemiology, pathogenesis, diagnosis, treatment, and prognosis
by: J. Čemerkaitė, et al.
Published: (2021-03-01)

Autoantibodies in myasthenia gravis: cluster analysis and clinical correlations
by: Xupeng Sun, et al.
Published: (2025-02-01)

Breaking New Ground: A Seropositive Neuromyelitis Optica (NMOSD) in Ethiopian Patients: A Case Series
by: Yegzeru Belete, et al.
Published: (2025-01-01)

Acute gastroenteritis and unilateral vision loss leading to a diagnosis of aquaporin-4-IgG seropositive neuromyelitis optica spectrum of disorders in a child: A case of atypical optic neuritis in the era of biomarkers
by: N Narainswami
Published: (2024-05-01)

Clinical characteristics of anti-myelin oligodendrocyte glycoprotein antibody among aquaporin-4 negative neuromyelitis optica spectrum disorders in Egyptian patients
by: Sara I. Taha, et al.
Published: (2025-01-01)

Analysis of changes in the chemokine CXC ligand 13 in serum and cerebrospinal fluid of patients with neuromyelitis optica
by: Juan Zhou, et al.
Published: (2025-01-01)

Rituximab in Refractory Myasthenia Gravis – Challenges and Lessons Learnt
by: Karthika A Valaparambil, et al.
Published: (2024-12-01)

Multiple Brain Abscesses in a Patient with Myasthenia Gravis – a Case Report
by: S. Radzevičiūtė, et al.
Published: (2023-12-01)

The Association Between Myasthenia Gravis and Higher Extrathymic Cancer Risk
by: Mohamed Khateb, et al.
Published: (2025-01-01)

Thalamic volume differentiates multiple sclerosis from neuromyelitis optica spectrum disorder: MRI-based retrospective study
by: Manal Alosaimi, et al.
Published: (2025-01-01)

New treatment options for generalized myasthenia gravis
by: Antanas Vaitkus, et al.
Published: (2024-02-01)

Surgical Treatment of the Oroantral Fistula in a Patient with Myasthenia Gravis: Clinical Considerations and Anesthetical Management
by: Elif Betül Yıldırım, et al.
Published: (2024-04-01)

Safety and efficacy of therapeutic plasma exchange in neuromyelitis optica: A retrospective study from South India
by: Dibyajyoti Sahoo, et al.
Published: (2024-12-01)

Co-occurrence of Myasthenia Gravis and Multiple Sclerosis: A Case Report
by: G. Rynkevič, et al.
Published: (2024-02-01)

Targeting NF-kappaB-inducing kinase shapes B-cell homeostasis in myasthenia gravis
by: Xiaoyu Huang, et al.
Published: (2025-01-01)

Diurnal cognitive functioning in patients with myasthenia gravis with the role of chronotype and depression: a pilot study
by: Monika Wiłkość-Dębczyńska, et al.
Published: (2024-07-01)

Efficacy of human umbilical cord mesenchymal stem cell in the treatment of neuromyelitis optica spectrum disorders: an animal study
by: Chunran Xue, et al.
Published: (2025-02-01)

Editorial: Surgical treatment of thymic epithelial tumor and myasthenia gravis
by: Piergiorgio Muriana
Published: (2025-01-01)

Trauma-Induced Double-Seronegative Ocular Myasthenia Gravis: A Case Report
by: Mohammad Ali Khalid, et al.
Published: (2024-06-01)

Association of Myasthenia Gravis With Autoimmune Thyroid Disease: A Bidirectional Mendelian Randomization Study
by: Yao Wang, et al.
Published: (2025-01-01)

Apheresis for the treatment of relapses in MS and NMOSD: reduced antibody reactivities, gene expression changes and potential clinical response indicators
by: Michael Hecker, et al.
Published: (2025-01-01)

Safety and efficacy of sugammadex in management of patients with myasthenia gravis undergoing general anesthesia: A systematic review
by: Alan D. Kaye, et al.
Published: (2025-01-01)

Prevalence and Risk Assessment of Obstructive Sleep Apnea in Myasthenia Gravis Patients Using the STOP-BANG Questionnaire
by: Mi-Ri Kang, et al.
Published: (2024-12-01)

Successful treatment of generalized myasthenia gravis with telitacicept: a Chinese case series and literature review
by: Xiaodong Song, et al.
Published: (2025-01-01)

Myasthenia gravis and Lambert-Eaton myasthenic syndrome: treatment options and guidance for management during COVID-19 pandemic
by: A. Klimašauskienė, et al.
Published: (2020-06-01)

Burden of Myasthenia Gravis in the Czech Republic: Analysis of the Nationwide Patient Registry
by: Stanislav Voháňka, et al.
Published: (2024-12-01)

Thymus Hyperplasia and Thymoma Type B in Patients with Myasthenia Gravis: Two case reports and Literature Review
by: Selman Dumani, et al.
Published: (2025-01-01)

Distal muscle weakness as the main onset symptom in thymoma-associated myasthenia gravis: a case report and literature review
by: Xuan Wu, et al.
Published: (2025-01-01)

Hemorrhagic Longitudinally Extensive Transverse Myelitis (LETM) as a First Presentation of Neuromyelitis Optica Spectrum Disorder (NMOSD): A Case Report and Literature Review
by: Shima Jahani, et al.
Published: (2025-01-01)

Racial disparities in acute care utilization among individuals with myasthenia gravis
by: Cynthia Qi, et al.
Published: (2025-02-01)

Case report: Efgartigimod is a novel therapeutic option for ocular myasthenia gravis: a report of 2 cases
by: Tianying Ma, et al.
Published: (2025-01-01)

Advances in the genetics of myasthenia gravis: insights from cutting-edge neuroscience research
by: Zheng Yixian, et al.
Published: (2025-01-01)

Elucidating genetic intersections: Co-differentially expressed genes in myasthenia gravis and idiopathic inflammatory myopathies and their role in comorbid pathogenesis
by: Wenqu Yang, et al.
Published: (2025-01-01)

Myasthenia gravis complicated by pure red cell aplasia with clonal large granular lymphocytosis in the absence of thymoma: a rare case report and literature review
by: Lijun Du, et al.
Published: (2025-02-01)

Jianpi Yiqi Busui prescription alleviates myasthenia gravis by regulating Th17 through the TAK1/P38 MAPK/eIF-4E signaling pathway
by: Zhuming Chen, et al.
Published: (2025-02-01)

Type B thymomas in patients with myasthenia gravis display a distinctive pattern of αβ TCR and IL-7 receptor α expression on CD4+CD8+ thymocytes
by: Tianlai Wang, et al.
Published: (2024-12-01)

Coexistence of Anti-GAD and Anti-GABAAR Antibodies in an Autoimmune Encephalitis Patient: A Case Report
by: Lu X, et al.
Published: (2025-01-01)

Case report: Successful perioperative intervention with efgartigimod in a patient in myasthenic crisis
by: Shahar Shelly
Published: (2025-01-01)

Pericardial Effusion as a First Symptom of Thymoma: A Case Report
by: Suprit Malali, et al.
Published: (2025-01-01)